Kistler-Tiffany Companies’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $2.01M | Buy |
54,934
+1,803
| +3% | +$70.2K | 0.33% | 61 |
|
|
2023
Q1 | $2.17M | Sell |
53,131
-599
| -1% | -$25.9K | 0.41% | 47 |
|
|
2022
Q4 | $2.75M | Sell |
53,730
-1,036
| -2% | -$49.7K | 0.57% | 33 |
|
|
2022
Q3 | $2.4M | Buy |
54,766
+1,377
| +3% | +$66.9K | 0.54% | 33 |
|
|
2022
Q2 | $2.8M | Buy |
53,389
+4,032
| +8% | +$205K | 0.61% | 31 |
|
|
2022
Q1 | $2.56M | Sell |
49,357
-1,872
| -4% | -$97.1K | 0.48% | 35 |
|
|
2021
Q4 | $3.02M | Sell |
51,229
-360
| -0.7% | -$17.8K | 0.59% | 29 |
|
|
2021
Q3 | $2.22M | Buy |
51,589
+1,061
| +2% | +$47K | 0.5% | 36 |
|
|
2021
Q2 | $1.98M | Buy |
50,528
+194
| +0.4% | +$7.54K | 0.46% | 41 |
|
|
2021
Q1 | $1.82M | Buy |
50,334
+50
| +0.1% | +$1.77K | 0.47% | 40 |
|
|
2020
Q4 | $1.85M | Sell |
50,284
-2,546
| -5% | -$93.4K | 0.53% | 35 |
|
|
2020
Q3 | $1.84M | Buy |
52,830
+4,939
| +10% | +$173K | 0.59% | 33 |
|
|
2020
Q2 | $1.49M | Buy |
47,891
+1,400
| +3% | +$47.6K | 0.53% | 33 |
|
|
2020
Q1 | $1.73M | Hold |
46,491
| – | – | 0.61% | 33 |
|
|
2019
Q4 | $1.73M | Buy |
46,491
+121
| +0.3% | +$4.31K | 0.61% | 33 |
|
|
2019
Q3 | $1.58M | Buy |
46,370
+3,917
| +9% | +$142K | 0.6% | 34 |
|
|
2019
Q2 | $1.75M | Sell |
42,453
-4,548
| -10% | -$181K | 0.66% | 31 |
|
|
2019
Q1 | $1.89M | Buy |
47,001
+573
| +1% | +$22.9K | 0.78% | 20 |
|
|
2018
Q4 | $1.92M | Buy |
46,428
+2,222
| +5% | +$92.2K | 0.89% | 19 |
|
|
2018
Q3 | $1.85M | Sell |
44,206
-3,160
| -7% | -$122K | 0.76% | 21 |
|
|
2018
Q2 | $1.63M | Sell |
47,366
-3,461
| -7% | -$118K | 0.72% | 24 |
|
|
2018
Q1 | $1.71M | Sell |
50,827
-4,329
| -8% | -$149K | 0.7% | 24 |
|
|
2017
Q4 | $1.9M | Buy |
55,156
+193
| +0.4% | +$6.58K | 0.75% | 23 |
|
|
2017
Q3 | $1.86M | Buy |
54,963
+5,314
| +11% | +$171K | 0.78% | 23 |
|
|
2017
Q2 | $1.58M | Buy |
49,649
+1,418
| +3% | +$44.7K | 0.73% | 29 |
|
|
2017
Q1 | $1.56M | Buy |
48,231
+2,877
| +6% | +$90.7K | 0.74% | 29 |
|
|
2016
Q4 | $1.4M | Sell |
45,354
-1,284
| -3% | -$39.2K | 0.68% | 29 |
|
|
2016
Q3 | $1.5M | Buy |
46,638
+1,983
| +4% | +$66.3K | 0.74% | 29 |
|
|
2016
Q2 | $1.49M | Buy |
44,655
+2,317
| +5% | +$73.9K | 0.77% | 29 |
|
|
2016
Q1 | $1.19M | Buy |
42,338
+689
| +2% | +$19.7K | 0.66% | 34 |
|
|
2015
Q4 | $1.3M | Sell |
41,649
-146
| -0.3% | -$4.59K | 0.72% | 31 |
|
|
2015
Q3 | $1.27M | Sell |
41,795
-563
| -1% | -$18.1K | 0.76% | 28 |
|
|
2015
Q2 | $1.35M | Buy |
42,358
+1,148
| +3% | +$37.4K | 0.81% | 25 |
|
|
2015
Q1 | $1.36M | Buy |
41,210
+291
| +0.7% | +$9.25K | 0.87% | 24 |
|
|
2014
Q4 | $1.21M | Sell |
40,919
-1,146
| -3% | -$32.9K | 0.79% | 28 |
|
|
2014
Q3 | $1.18M | Buy |
42,065
+2,068
| +5% | +$58K | 0.79% | 28 |
|
|
2014
Q2 | $1.13M | Buy |
39,997
+197
| +0.5% | +$5.62K | 0.82% | 31 |
|
|
2014
Q1 | $1.21M | Buy |
39,800
+559
| +1% | +$16.7K | 0.9% | 24 |
|
|
2013
Q4 | $1.14M | Sell |
39,241
-504
| -1% | -$14.7K | 0.85% | 27 |
|
|
2013
Q3 | $1.08M | Buy |
39,745
+1,099
| +3% | +$29.9K | 0.87% | 31 |
|
|
2013
Q2 | $1.03M | Buy |
+38,646
| New | +$1.07M | 0.88% | 33 |
|
Other funds holding PFE
Kistler-Tiffany Companies's PFE Position: Q2 2023 in Review
Kistler-Tiffany Companies increased its Pfizer (PFE) stake by 3.4% in Q2 2023, buying an estimated $70.2K and bringing the position to 54,934 shares worth $2.01M. The position accounts for 0.33% of the portfolio, ranked #61.
Kistler-Tiffany Companies first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $3.02M in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.
- Kistler-Tiffany Companies held 54,934 shares of Pfizer worth $2.01M as of Q2 2023.
- Kistler-Tiffany Companies bought 1,803 Pfizer shares in Q2 2023, an estimated $70.2K.
- Pfizer made up 0.33% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #61 holding.
- Kistler-Tiffany Companies first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
- Kistler-Tiffany Companies's Pfizer position peaked at $3.02M in Q4 2021.
- 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.
Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.